Rpld Part FFF §§1 & 1-a, Chap 56 of 2020; add §365-i, rpld §364-j sub 4 ¶(u), subs 25 - 26-b, Soc Serv L; amd
§273, Pub Health L
Provides that prescription drugs eligible for reimbursement shall be provided and paid for under the preferred drug program and the clinical drug review program; restores pharmacy benefits under Medicaid managed care.
STATE OF NEW YORK
________________________________________________________________________
7200--A
2021-2022 Regular Sessions
IN ASSEMBLY
April 29, 2021
___________
Introduced by M. of A. GOTTFRIED, STECK, McDONALD -- read once and
referred to the Committee on Health -- recommitted to the Committee on
Ways and Means in accordance with Assembly Rule 3, sec. 2 -- committee
discharged, bill amended, ordered reprinted as amended and recommitted
to said committee
AN ACT to amend the social services law, in relation to prescription
drugs eligible for Medicaid coverage; to amend the public health law,
in relation to prior authorization under the preferred drug program;
to repeal certain provisions of part FFF of chapter 56 of the laws of
2020 directing the department of health to remove the pharmacy benefit
from the managed care benefit package, relating to restoring such
benefits; and to repeal certain provisions of the social services law,
relating to coverage for certain prescription drugs under Medicaid
managed care programs
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Legislative findings. This legislature finds that the costs
2 of many prescription drugs in the market have been escalating unreason-
3 ably. The preferred drug program and the clinical drug review program
4 under the public health law provide effective mechanisms for assuring
5 access to quality, effective and safe drugs to patients at reasonable
6 cost. Providing prescription drugs to Medicaid managed health care
7 provider participants through these programs will maximize the Medicaid
8 program's ability to negotiate more substantial rebates with drug
9 manufacturers (effectively, lower prices), while protecting Medicaid
10 managed care provider participants.
11 § 2. Sections 1 and 1-a of part FFF of chapter 56 of the laws of 2020,
12 relating to prescription drugs under the Medicaid program, are REPEALED.
13 § 3. The social services law is amended by adding a new section 365-i
14 to read as follows:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD11099-02-2
A. 7200--A 2
1 § 365-i. Prescription drugs in Medicaid. 1. The definitions of terms
2 in section two hundred seventy of the public health law shall apply to
3 this section. As used in this section, unless the context clearly
4 requires otherwise, "managed care provider" means a managed care provid-
5 er under section three hundred sixty-four-j of this article, or a
6 managed long term care plan under section forty-four hundred three-f of
7 the public health law.
8 2. Prescription drugs eligible for reimbursement under this article
9 shall be provided and paid for under the preferred drug program and the
10 clinical drug review program under title one of article two-A of the
11 public health law, except as otherwise provided in subdivision three of
12 this section.
13 3. This subdivision applies where the eligible individual is enrolled
14 in a managed care provider and a prescription for the eligible individ-
15 ual is made under section 340B of the federal Public Health Service Act
16 (the "340B program"). The managed care provider shall pay for the drugs
17 under the 340B program. However, the prescription shall be subject to
18 section two hundred seventy-three (preferred drug program prior authori-
19 zation) and section two hundred seventy-four (clinical drug review
20 program) of the public health law.
21 4. The managed care provider shall account to and reimburse the
22 department for the net cost to the department for prescription drugs
23 provided to eligible individuals who receive medical services from the
24 managed care provider. Capitation payments by the department to such
25 managed care provider shall include a component for reimbursements paid
26 under this subdivision.
27 § 4. Paragraph (b) of subdivision 3 of section 273 of the public
28 health law, as added by section 10 of part C of chapter 58 of the laws
29 of 2005, is amended to read as follows:
30 (b) In the event that the patient does not meet the criteria in para-
31 graph (a) of this subdivision, the prescriber may provide additional
32 information to the program to justify the use of a prescription drug
33 that is not on the preferred drug list. The program shall provide a
34 reasonable opportunity for a prescriber to reasonably present his or her
35 justification of prior authorization. If, after consultation with the
36 program, the prescriber, in his or her reasonable professional judgment,
37 determines that the use of a prescription drug that is not on the
38 preferred drug list is warranted, the prescriber's determination shall
39 be final. However, the prescriber's determination shall not be final:
40 (i) where the preferred drug is a generic drug subject to subparagraph
41 (i) of paragraph (a-1) of subdivision four of section three hundred
42 sixty-five-a of the social services law (mandatory generic substi-
43 tution), and even if the prescriber has indicated that the prescription
44 shall be dispensed as written; or (ii) if it is for the use of a drug
45 that is not consistent with food and drug administration-approved label-
46 ing or supported by one or more official Compendia references, includ-
47 ing, but not limited to, the American Hospital Formulary Service (AHFS),
48 the DRUGDEX Drug Information System and the United States Pharmacopeia.
49 § 5. Subdivisions 25, 25-a, 26 and 26-b, and paragraph (u) of subdivi-
50 sion 4 of section 364-j of the social services law are REPEALED.
51 § 6. Severability. If any provision of this act, or any application of
52 any provision of this act, is held to be invalid, or to violate or be
53 inconsistent with any federal law or regulation, that shall not affect
54 the validity or effectiveness of any other provision of this act, or of
55 any other application of any provision of this act, which can be given
A. 7200--A 3
1 effect without that provision or application; and to that end, the
2 provisions and applications of this act are severable.
3 § 7. This act shall take effect immediately, except that sections one
4 through five of this act shall take effect on the one hundred eightieth
5 day after they shall have become a law. Effective immediately, the
6 commissioner of health shall make regulations and take other actions
7 reasonably necessary to implement this act when it takes effect.
